The Discounted Cash Flow (DCF) valuation of Cardiff Oncology Inc (CRDF) is (14.08) USD. With the latest stock price at 3.81 USD, the upside of Cardiff Oncology Inc based on DCF is -469.5%.
Based on the latest price of 3.81 USD and our DCF valuation, Cardiff Oncology Inc (CRDF) is a sell. selling Cardiff stocks now will result in a potential gain of 469.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.6% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (79.73) - (7.83) | (14.08) |
| Upside | -2192.6% - -305.6% | -469.5% |